Primetime Bioethics

Bioethicists delve into some fascinating questions about some of the most difficult choices involved in medicine, wrestling with crucibles about the when to treat and when not to, the limits of human life, human potential, the quality of life, and even what it means to be human.

These intriguing questions are the bioethicist's daily grind. But just because the questions can be intriguing does not mean the lives of bioethicists are all that exciting. Certainly a life spent writing reports, plotting charts, and skimming law journals would not make for good television.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.